These are nothing compared to the challenges faced by CF care teams in low and middle-income countries; even before high-cost CFTR modulators were developed, there were large differences globally in the provision of funding and expertise for CF care which was broadly reflected in survival94,95. Here, CFTR is linked to cystic fibrosis.